

[ Mon, Aug 19th 2024
] - WOPRAI

[ Tue, Jul 02nd 2024
] - WOPRAI

[ Fri, Jun 21st 2024
] - WOPRAI

[ Wed, Aug 09th 2023
] - WOPRAI

[ Fri, Jun 30th 2023
] - WOPRAI

[ Tue, Jun 20th 2023
] - WOPRAI

[ Wed, May 17th 2023
] - WOPRAI

[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI

[ Mon, Mar 27th 2023
] - WOPRAI

[ Thu, Mar 09th 2023
] - WOPRAI

[ Tue, Mar 07th 2023
] - WOPRAI

[ Fri, Jan 06th 2023
] - WOPRAI

[ Fri, Dec 16th 2022
] - WOPRAI

[ Thu, Apr 14th 2022
] - WOPRAI

[ Tue, Jan 04th 2022
] - WOPRAI

[ Wed, Dec 01st 2021
] - WOPRAI

[ Mon, Nov 29th 2021
] - WOPRAI

[ Thu, Nov 11th 2021
] - WOPRAI

[ Fri, Sep 10th 2021
] - WOPRAI

[ Mon, Aug 09th 2021
] - WOPRAI

[ Wed, Dec 23rd 2020
] - WOPRAI

[ Tue, Dec 15th 2020
] - WOPRAI

[ Mon, Aug 17th 2020
] - WOPRAI

[ Thu, Jul 30th 2020
] - WOPRAI

[ Tue, Jul 28th 2020
] - WOPRAI

[ Mon, Jul 20th 2020
] - WOPRAI

[ Tue, Nov 19th 2019
] - WOPRAI

[ Tue, Oct 22nd 2019
] - WOPRAI


[ Mon, Dec 17th 2018
] - WOPRAI

[ Wed, Aug 08th 2018
] - WOPRAI

[ Thu, May 24th 2018
] - WOPRAI


[ Mon, Feb 12th 2018
] - WOPRAI

[ Wed, Oct 25th 2017
] - WOPRAI

[ Thu, Oct 12th 2017
] - WOPRAI
Elemer Piros Initiated (ATHA) at Strong Buy and Held Target at $22 on, Aug 19th, 2024
Elemer Piros of Rodman & Renshaw, Initiated "Athira Pharma, Inc." (ATHA) at Strong Buy and Held Target at $22 on, Aug 19th, 2024.
Elemer has made no other calls on ATHA in the last 4 months.
There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Elemer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Elemer
- Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $19 on, Thursday, June 20th, 2024